Search Results

CSL Seqirus employs both egg and cell-based manufacturing systems to ensure the availability of our influenza vaccines. Learn more about our optimised technology.

https://www.cslseqirus.com/manufacturing/technologies

ESWI and CSL Seqirus look to award a third young scientist tackling influenza head on.

https://www.cslseqirus.com/vita/2022/kickstarting-the-future-of-vaccine-innovators

CSL Seqirus is one of the largest influenza vaccine companies in the world, with state-of-the-art manufacturing facilities on three continents. Learn more.

https://www.cslseqirus.com/manufacturing/global-manufacturing-network

CSL Seqirus is a world leader in developing and producing influenza vaccines. Learn more about how we work with our partners to protect the global community.

https://www.cslseqirus.com/products

We produce antivenoms for Australia's most dangerous creatures and Q fever vaccines to protect people working with livestock. Learn about these unique products.

https://www.cslseqirus.com/expertise/antivenom-and-q-fever-vaccines

CSL Seqirus stands with our partners on the front line of public health. We are the largest fully integrated commercialisation partner in Australia and New Zealand. Learn more.

https://www.cslseqirus.com/partnering

Understand our aim to develop the next generation of influenza vaccines and how we're working to unite product platforms across the globe.

https://www.cslseqirus.com/manufacturing/technical-development

Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.

https://www.cslseqirus.com/

We are committed to ensuring early and reliable supply of influenza vaccines using both egg and cell-based manufacturing technologies.

https://www.cslseqirus.com/manufacturing

CSL Seqirus delivered a record 135 million doses of flu vaccines globally last year, here’s how we make such a feat happen.

https://www.cslseqirus.com/vita/2022/the-art-and-science-of-shipping-flu-vaccines